Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …

BACKGROUND Recent studies show a mechanistic link between intestinal microbial
metabolism of dietary phosphatidylcholine and coronary artery disease pathogenesis …

Aims The trimethylamine N-oxide (TMAO) pathway is related to intestinal microbiota and has
been associated to risk of cardiovascular disease (CVD). We investigated associations …

Production of trimethylamine-N-oxide (TMAO) via the gut microbiota has recently been
proposed as an important pathophysiological mechanism linking ingestion of 'unhealthy …

Trimethylamine N-oxide (TMAO), a novel cardiovascular (CV) disease and mortality risk
marker, is a gut microbiota-derived metabolite as well. Recently, plasma concentrations of …

Aims Gut microbiota-derived metabolite trimethylamine-N-oxide (TMAO) is emerging as a
new potentially important cause of increased cardiovascular risk. The purpose of this meta …

Trimethylamine N-oxide (TMAO) is a circulating metabolite that has been implicated in the
development of atherosclerosis and cardiovascular disease (CVD). In this paper, we identify …

Diet has been considered a general health determinant for many years. Recent research
shows a connection between gut microbiota composition that is shaped by our diet and …

ABSTRACT Background Trimethylamine N-oxide (TMAO) is a diet-and microbiome-derived
metabolite and a proposed biomarker of adverse cardiometabolic outcomes. TMAO studies …

The prevalence of diabetes is steadily rising, and once it occurs, it can cause multiple
complications with a negative impact on the whole organism. Complications of diabetes may …